Bpifrance SA Long-Term Concentrated

CIK: 0001731118 · Show all filings

Period: Q4 2018 (Next →)

Filing Date: Nov 14, 2019

Total Value ($000): $782,364 (100.0% shares, 0.0% debt)

Holdings (9)

FTI TECHNIPFMC PLC 63.8%

Value ($000) $498,940 Shares 24,688,691 Est. Cost $17.41 Unrealized 0.0%

— CONSTELLIUM NV 14.6%

Value ($000) $114,593 Shares 16,393,903 Est. Cost $6.99 Unrealized —

— TALEND S A 10.0%

Value ($000) $78,346 Shares 2,112,895 Est. Cost $37.08 Unrealized —

CRTO CRITEO S A 7.9%

Value ($000) $61,770 Shares 2,718,752 Est. Cost $22.72 Unrealized —

— SEQUANS COMMUNICATIONS S A 1.2%

Value ($000) $9,427 Shares 12,085,561 Est. Cost $0.78 Unrealized —

— MILLENDO THERAPEUTICS INC 1.1%

Value ($000) $8,575 Shares 1,078,670 Est. Cost $7.95 Unrealized —

— DBV TECHNOLOGIES S A 0.7%

Value ($000) $5,348 Shares 833,042 Est. Cost $6.42 Unrealized —

MITK MITEK SKS INC 0.4%

Value ($000) $2,756 Shares 254,941 Est. Cost $9.04 Unrealized 0.0%

— ADVERUM BIOTECHNOLOGIES INC 0.3%

Value ($000) $2,609 Shares 828,262 Est. Cost $3.15 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
FTI	TECHNIPFMC PLC	24,688,691	$498,940	63.8%	$17.41	0.0%	COM	G87110105
—	CONSTELLIUM NV	16,393,903	$114,593	14.6%	$6.99	—	CL A	N22035104
—	TALEND S A	2,112,895	$78,346	10.0%	$37.08	—	ADS	874224207
CRTO	CRITEO S A	2,718,752	$61,770	7.9%	$22.72	—	SPONS ADS	226718104
—	SEQUANS COMMUNICATIONS S A	12,085,561	$9,427	1.2%	$0.78	—	SPONS ADS	817323108
—	MILLENDO THERAPEUTICS INC	1,078,670	$8,575	1.1%	$7.95	—	COM	60040X103
—	DBV TECHNOLOGIES S A	833,042	$5,348	0.7%	$6.42	—	SPONSORED ADR	23306J101
MITK	MITEK SKS INC	254,941	$2,756	0.4%	$9.04	0.0%	COM NEW	606710200
—	ADVERUM BIOTECHNOLOGIES INC	828,262	$2,609	0.3%	$3.15	—	COM	00773U108